Diabetes insipidus pathophysiology: Difference between revisions

Jump to navigation Jump to search
 
(24 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Diabetes insipidus}}
{{Diabetes insipidus}}
{{CMG}}
{{CMG}}; {{AE}} {{DAMI}}
==Overview==
==Overview==
The [[posterior pituitary]] consists of the [[Paraventricular nucleus of hypothalamus|paraventricular]] and [[Supraoptic nucleus|supraoptic nuclei]], which synthesize [[oxytocin]] and [[arginine vasopressin|arginine vasopressin,]] respectively. In cases of [[Central diabetes insipidus|central DI]], there is an absence of [[vasopressin]], which is responsive to the exogenous administration of [[desmopressin]]. On the contrary, in cases of [[Nephrogenic diabetes insipidus|nephrogenic DI]], [[solute]] excretion and all filtration functions of the [[kidney]] are normal, but [[urine]] is [[hypotonic]] and there is a characteristic resistance to the [[antidiuretic]] effects of both [[endogenous]] and [[exogenous]] administration of [[vasopressin]]. More than 55 different [[genetic mutations]] resulting in a defective [[prohormone]] and a deficiency of [[ADH]] have been identified in familial [[Central diabetes insipidus|central diabetes]]. Many conditions have been associated with the development of [[diabetes insipidus]] such as [[Wolfram syndrome]] (also known as DIDMOAD), [[Langerhans cell histiocytosis]] (LCH), [[Sickle-cell disease|sickle cell disease]], [[amyloidosis]], and several others.
==Pathogenesis==
==Pathogenesis==
===Central Diabetes insipidus===
===Central Diabetes Insipidus===
The posterior pituitary consists of paraventricular and the supra-optic nuclei that synthesizes oxytocin and arginine vasopressin respectively. The axons of these hormones project to the neurohypophysis where the hormones are secreted into the blood stream to allow maximum antidiuresis for 5–10 days.
The [[posterior pituitary]] consists of the [[Paraventricular nucleus|paraventricular]] and [[Supraoptic nucleus|supraoptic]] nuclei that synthesize [[oxytocin]] and [[arginine vasopressin]], respectively. The [[axons]] of these [[hormones]] project to the [[neurohypophysis]], where the [[hormones]] are secreted into the [[blood stream|bloodstream]] to allow for maximum anti-diuresis over the course of 5–10 days. The maintenance of water balance in healthy humans is achieved principally by three interrelated determinants:  
The maintenance of water balance in healthy humans is achieved principally by three interrelated determinants:  
*[[Thirst]]
*Thirst
*[[ADH|AVP]]
*AVP  
*[[Kidney]] function
*Kidney function
[[ADH]] acts on the [[kidney]], where it increases [[urine osmolality]]. It binds to the [[V2 receptor|V2 receptors]] in the [[basolateral membrane]] of the [[Collecting duct system|renal collecting tube]] and activates the [[Adenyl cyclases|Gs-adenyl cyclase]] system, increasing intracellular levels of [[Cyclic adenosine monophosphate|cyclic 3′,5′-adenosine monophosphate]] ([[Cyclic adenosine monophosphate|cAMP]]) and thus activating [[protein kinase A]], which in turn phosphorylates preformed [[Aquaporin 2|AQP2 water channels]] localized in intracellular [[vesicles]].<ref name="pmid16209125">{{cite journal| author=Agre P| title=Nobel Lecture. Aquaporin water channels. | journal=Biosci Rep | year= 2004 | volume= 24 | issue= 3 | pages= 127-63 | pmid=16209125 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16209125  }} </ref>
AVP acts on the kidney, where it increases urine osmolality. It binds to the V2-receptors in the basolateral membrane of the renal collecting tube and activates the Gs-adenyl cyclase system, increasing intracellular levels of cyclic 3′,5′-adenosine monophosphate (cAMP) activating protein kinase A, which in turn phosphorylates preformed AQP2 water channels localized in intracellular vesicles.<ref name="pmid16209125">{{cite journal| author=Agre P| title=Nobel Lecture. Aquaporin water channels. | journal=Biosci Rep | year= 2004 | volume= 24 | issue= 3 | pages= 127-63 | pmid=16209125 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16209125  }} </ref>
 
===Nephrogenic Diabetes Insipidus===
In cases of [[Nephrogenic diabetes insipidus|nephrogenic DI]], [[solute]] [[excretion]] and all [[filtration]] functions of the [[kidney]] are normal, but [[urine]] is [[hypotonic]] and there is a characteristic resistance to the [[antidiuretic]] effects of [[endogenous]] [[vasopressin]]. Abnormalities in the [[medullary]] [[osmotic]] [[gradient]], directed by [[antidiuretic  hormone]] ([[ADH]]) or [[arginine vasopressin]] ([[AVP]]) and inhibition of the action of [[ADH]] on the [[renal tubules]], are both thought to be mechanisms by which [[Nephrogenic diabetes insipidus|nephrogenic DI]] develops. The lack of response to [[ADH]] is due to the inhibition of  [[adenylate cyclase]] and the resultant decreased formation of [[Cyclic adenosine monophosphate|cAMP]]. [[cAMP]] serves as a second messenger to [[Protein kinase A|protein kinase A]] and facilitates the fusion of [[aquaporin]] storage vesicles to the [[luminal]] cell wall, which in turn allows the [[Collecting duct system|collecting ducts]] to become [[permeable]] and reabsorb water.


===Psychogenic Diabetes Insipidus===
This [[Disorder (medicine)|disorder]] is also known as [[Factitious disorder|factitious]] diabetes insipidus, a condition whereby, due to some [[psychological]] [[Disorder (medicine)|disorder]], a patient drinks an excessive amount of water, thereby decreasing the [[plasma osmolarity]] and suppressing the release of [[ADH]]. This leads to [[polyuria]]. The presence of a psychoneurotic disorder, the absence of a preference for iced fluids, and prompt [[Antidiuretic effect|antidiuresis]] in response to the administration of [[Hypertonic|hypertonic saline,]] [[nicotine]], or water deprivation will usually establish the [[diagnosis]].


===Nephrogenic diabetes insipidus===
===Gestational Diabetes Insipidus===
In nephrogenic DI, solute excretion and all filtration functions of the kidney are normal but urine is hypotonic and there is a characteristic resistance to the antidiuretic effects of endogenous vasopressin. Abnormalities in the medullary osmotic  gradient  directed  by antidiuretic  hormone (ADH) or arginine vasopressin (AVP) and inhibition of the action of ADH on  the renal tubules  are both thought to be mechanisms of development of nephrogenic DI. The lack of response to  ADH  is due  to the inhibition  of adenylate cyclase  and resultant  decreased  formation  of cyclic  cAMP. cAMP  serves  as  a  second  messenger  to  protein  kinase  A  and  the  fusion  of aquaporin  storage  vesicles  to  the  luminal  cell wall, which in turn allows the collecting ducts to become  permeable  and  reabsorb  water.
This disorder is classically identified during [[pregnancy]] in a woman of childbearing age. Gestational diabetes insipidus (DI) is a very rare [[complication]] of pregnancy. Undiagnosed and untreated cases may lead to serious complications in both the mother and the fetus. Gestational DI results when an [[enzyme]] made by the [[placenta]] destroys [[ADH]] in the mother. The [[placenta]] is the system of [[blood vessels]] and other tissues that develops with the [[fetus]]. The [[placenta]] allows for the exchange of [[nutrients]] and waste products between mother and [[fetus]]. Most cases of gestational DI can be treated with [[desmopressin]]. In rare cases, however, an abnormality in the thirst mechanism causes gestational DI, and [[desmopressin]] should not be used.<ref name="pmid26707038">{{cite journal| author=Ejmocka-Ambroziak A, Grzechocińska B, Jastrzebska H, Kochman M, Cyganek A, Wielgoś M et al.| title=Gestational diabetes insipidus. Case Report. | journal=Neuro Endocrinol Lett | year= 2015 | volume= 36 | issue= 5 | pages= 410-3 | pmid=26707038 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26707038 }} </ref>


==Genetics==
==Genetics==
*More than 55 different genetic mutations resulting in a defective prohormone and a deficiency of AVP have been identified in familial central diabetes.<ref name="ChristensenRittig2006">{{cite journal|last1=Christensen|first1=Jane H.|last2=Rittig|first2=Søren|title=Familial Neurohypophyseal Diabetes Insipidus—An Update|journal=Seminars in Nephrology|volume=26|issue=3|year=2006|pages=209–223|issn=02709295|doi=10.1016/j.semnephrol.2006.03.003}}</ref><ref name="GhirardelloGarrè2007">{{cite journal|last1=Ghirardello|first1=S.|last2=Garrè|first2=M.-L.|last3=Rossi|first3=A.|last4=Maghnie|first4=M.|title=The Diagnosis of Children with Central Diabetes Insipidus|journal=Journal of Pediatric Endocrinology and Metabolism|volume=20|issue=3|year=2007|issn=2191-0251|doi=10.1515/JPEM.2007.20.3.359}}</ref>
More than 55 different [[genetic mutations]] resulting in a defective [[prohormone]] and a deficiency of [[AVP]] have been implicated in the development of familial [[Central diabetes insipidus|central diabetes]].<ref name="ChristensenRittig2006">{{cite journal|last1=Christensen|first1=Jane H.|last2=Rittig|first2=Søren|title=Familial Neurohypophyseal Diabetes Insipidus—An Update|journal=Seminars in Nephrology|volume=26|issue=3|year=2006|pages=209–223|issn=02709295|doi=10.1016/j.semnephrol.2006.03.003}}</ref> The majority of relevant [[genetic mutations]] have an [[autosomal dominant]] form of inheritance.<ref name="GhirardelloGarrè2007">{{cite journal|last1=Ghirardello|first1=S.|last2=Garrè|first2=M.-L.|last3=Rossi|first3=A.|last4=Maghnie|first4=M.|title=The Diagnosis of Children with Central Diabetes Insipidus|journal=Journal of Pediatric Endocrinology and Metabolism|volume=20|issue=3|year=2007|issn=2191-0251|doi=10.1515/JPEM.2007.20.3.359}}</ref>
*Majority have an autosomal dominant form of inheritance


==Associated Conditions==
==Associated Conditions==
*Sickle   cell   disease
Conditions associated with DI include:
*Amyloidosis,
*[[Langerhans cell histiocytosis]] (LCH)
*Obstructive uropathy
*[[Wolfram syndrome]], also known as DIDMOAD ([[diabetes insipidus]], [[Diabetes mellitus|diabetes mellitus,]] [[Optic atrophy|optic atrophy,]] and [[deafness]])
*Electrolyte disorders (e.g.,hypokalemia and hypercalcemia),  
*[[Sickle-cell disease|Sickle cell disease]]
*Pregnancy
*[[Amyloidosis]]
*Conditions induced by a drug (e.g., lithium, demeclocycline, Amphotericin      B       and
*[[Obstructive uropathy]]
vincristine)
*[[Electrolyte disturbance|Electrolyte disturbances]] (e.g., [[hypokalemia]] and [[hypercalcemia]])   
*Lithium is the most  common cause of drug-induced nephrogenic DI
*[[Pregnancy]]
*Conditions induced by a drug (e.g., [[lithium]], [[demeclocycline]], [[amphotericin B]], and [[vincristine]])
**[[Lithium]] is the most  common cause of drug-induced [[Nephrogenic diabetes insipidus|nephrogenic DI]]
 
==Gross Pathology==
==Gross Pathology==
There are no gross pathology findings associated with diabetes insipidus.


==Microscopic Pathology==
==Microscopic Pathology==
*
There are no microscopic findings associated with diabetes insipidus.
 
==References==
==References==
{{reflist|2}}
{{reflist|2}}
Line 39: Line 49:
[[Category:Endocrinology]]
[[Category:Endocrinology]]
[[Category:Nephrology]]
[[Category:Nephrology]]
[[Category:Needs overview]]

Latest revision as of 19:49, 26 October 2017

Diabetes insipidus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Diabetes insipidus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT scan

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Diabetes insipidus pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Diabetes insipidus pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Diabetes insipidus pathophysiology

CDC on Diabetes insipidus pathophysiology

Diabetes insipidus pathophysiology in the news

Blogs on Diabetes insipidus pathophysiology

Directions to Hospitals Treating Diabetes insipidus

Risk calculators and risk factors for Diabetes insipidus pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]

Overview

The posterior pituitary consists of the paraventricular and supraoptic nuclei, which synthesize oxytocin and arginine vasopressin, respectively. In cases of central DI, there is an absence of vasopressin, which is responsive to the exogenous administration of desmopressin. On the contrary, in cases of nephrogenic DI, solute excretion and all filtration functions of the kidney are normal, but urine is hypotonic and there is a characteristic resistance to the antidiuretic effects of both endogenous and exogenous administration of vasopressin. More than 55 different genetic mutations resulting in a defective prohormone and a deficiency of ADH have been identified in familial central diabetes. Many conditions have been associated with the development of diabetes insipidus such as Wolfram syndrome (also known as DIDMOAD), Langerhans cell histiocytosis (LCH), sickle cell disease, amyloidosis, and several others.

Pathogenesis

Central Diabetes Insipidus

The posterior pituitary consists of the paraventricular and supraoptic nuclei that synthesize oxytocin and arginine vasopressin, respectively. The axons of these hormones project to the neurohypophysis, where the hormones are secreted into the bloodstream to allow for maximum anti-diuresis over the course of 5–10 days. The maintenance of water balance in healthy humans is achieved principally by three interrelated determinants:

ADH acts on the kidney, where it increases urine osmolality. It binds to the V2 receptors in the basolateral membrane of the renal collecting tube and activates the Gs-adenyl cyclase system, increasing intracellular levels of cyclic 3′,5′-adenosine monophosphate (cAMP) and thus activating protein kinase A, which in turn phosphorylates preformed AQP2 water channels localized in intracellular vesicles.[1]

Nephrogenic Diabetes Insipidus

In cases of nephrogenic DI, solute excretion and all filtration functions of the kidney are normal, but urine is hypotonic and there is a characteristic resistance to the antidiuretic effects of endogenous vasopressin. Abnormalities in the medullary osmotic gradient, directed by antidiuretic hormone (ADH) or arginine vasopressin (AVP) and inhibition of the action of ADH on the renal tubules, are both thought to be mechanisms by which nephrogenic DI develops. The lack of response to ADH is due to the inhibition of adenylate cyclase and the resultant decreased formation of cAMP. cAMP serves as a second messenger to protein kinase A and facilitates the fusion of aquaporin storage vesicles to the luminal cell wall, which in turn allows the collecting ducts to become permeable and reabsorb water.

Psychogenic Diabetes Insipidus

This disorder is also known as factitious diabetes insipidus, a condition whereby, due to some psychological disorder, a patient drinks an excessive amount of water, thereby decreasing the plasma osmolarity and suppressing the release of ADH. This leads to polyuria. The presence of a psychoneurotic disorder, the absence of a preference for iced fluids, and prompt antidiuresis in response to the administration of hypertonic saline, nicotine, or water deprivation will usually establish the diagnosis.

Gestational Diabetes Insipidus

This disorder is classically identified during pregnancy in a woman of childbearing age. Gestational diabetes insipidus (DI) is a very rare complication of pregnancy. Undiagnosed and untreated cases may lead to serious complications in both the mother and the fetus. Gestational DI results when an enzyme made by the placenta destroys ADH in the mother. The placenta is the system of blood vessels and other tissues that develops with the fetus. The placenta allows for the exchange of nutrients and waste products between mother and fetus. Most cases of gestational DI can be treated with desmopressin. In rare cases, however, an abnormality in the thirst mechanism causes gestational DI, and desmopressin should not be used.[2]

Genetics

More than 55 different genetic mutations resulting in a defective prohormone and a deficiency of AVP have been implicated in the development of familial central diabetes.[3] The majority of relevant genetic mutations have an autosomal dominant form of inheritance.[4]

Associated Conditions

Conditions associated with DI include:

Gross Pathology

There are no gross pathology findings associated with diabetes insipidus.

Microscopic Pathology

There are no microscopic findings associated with diabetes insipidus.

References

  1. Agre P (2004). "Nobel Lecture. Aquaporin water channels". Biosci Rep. 24 (3): 127–63. PMID 16209125.
  2. Ejmocka-Ambroziak A, Grzechocińska B, Jastrzebska H, Kochman M, Cyganek A, Wielgoś M; et al. (2015). "Gestational diabetes insipidus. Case Report". Neuro Endocrinol Lett. 36 (5): 410–3. PMID 26707038.
  3. Christensen, Jane H.; Rittig, Søren (2006). "Familial Neurohypophyseal Diabetes Insipidus—An Update". Seminars in Nephrology. 26 (3): 209–223. doi:10.1016/j.semnephrol.2006.03.003. ISSN 0270-9295.
  4. Ghirardello, S.; Garrè, M.-L.; Rossi, A.; Maghnie, M. (2007). "The Diagnosis of Children with Central Diabetes Insipidus". Journal of Pediatric Endocrinology and Metabolism. 20 (3). doi:10.1515/JPEM.2007.20.3.359. ISSN 2191-0251.

Template:WH Template:WS